GlassScriptPhysician profile
Marco A Jarrett
NPI 1073760773
$11,235.48
in general payments reported to CMS, 2019-2025
26 companies · $3,084 in 2025
The $3,084 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,004 · 2020: $341 · 2021: $443 · 2022: $630 · 2023: $269 · 2024: $4,464 · 2025: $3,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,200 · Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,200.00 |
| Food and Beverage | $617.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $7,200.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $1,873.73 | 2019-2020 | |
| Abbvie INC. | $323.89 | 2019-2023 | |
| Aspira Women'S Health INC | $278.74 | 2021-2023 | Ova1 |
| Coopersurgical, INC. | $243.49 | 2019-2024 | Paragard T 380a, Summit Doppler, Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $216.25 | 2019-2025 | |
| Organon LLC | $184.14 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $148.46 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Aptima |
| Daiichi Sankyo INC. | $147.62 | 2019-2022 | |
| Smith+Nephew, INC. | $83.81 | 2019-2023 | Pico, Pico 14 |
| Sage Therapeutics, LLC | $63.95 | 2024-2025 | Zurzuvae |
| Channel Medsystems, INC. | $55.62 | 2022 | |
| Avion Pharmaceuticals | $49.61 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $49.15 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $46.86 | 2024 | Myfembree |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $46.60 | 2023-2024 | Accrufer |
| Astellas Pharma US INC | $43.51 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $33.58 | 2022-2023 | |
| Ethicon US, LLC | $29.84 | 2019 | |
| Allergan, INC. | $29.38 | 2019-2020 | |
| Exeltis, USA INC. | $23.51 | 2020-2021 | |
| Exact Sciences Corporation | $14.35 | 2023 | Cologuard Collection Kit |
| Axonics, INC. | $12.97 | 2023 | Axonics |
| Agile Therapeutics, INC. | $12.89 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.83 | 2022 | |
| Minerva Surgical, INC | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.